Results 71 to 80 of about 2,013 (145)

Beyond the numbers: Critical analysis of the role of postmortem tryptase in the forensic diagnosis of anaphylaxis

Journal of Forensic Sciences, Volume 70, Issue 6, Page 2117-2128, November 2025.
Abstract The postmortem diagnosis of anaphylaxis remains a forensic challenge due to the lack of specific external signs. Tryptase, a mast cell‐derived protease, has emerged as a potential biomarker for fatal anaphylaxis. This systematic review critically examined 40 studies published between 2014 and 2024, including both biochemical and ...
Luca Tomassini, Giulia Ricchezze, Cristiana Gambelunghe, Massimo Lancia, Marco Gramaccia, Francesco De Micco, Piergiorgio Fedeli, Mariano Cingolani, Roberto Scendoni   +8 more
wiley   +1 more source

Indolent systemic mastocytosis in a child: A rare and difficult diagnosis

Indian Journal of Paediatric Dermatology, 2016
Mastocytosis is a sporadic disease characterized by an abnormal accumulation of mast cells (MCs) in single or multiple organs. A 5-year-old girl who was diagnosed as cutaneous mastocytosis by our Dermatology Department when she was 4 months of age was ...
Yasemin Altuner Torun, Ayse Betul Ergul, Elif Guler Kazancı, Mahmut Can Serbetci, Fatma Mutlu Sarıguzel   +4 more
doaj   +1 more source

Advances in the understanding and clinical management of mastocytosis and clonal mast cell activation syndromes [version 1; referees: 2 approved]

F1000Research, 2016
Clonal mast cell activation syndromes and indolent systemic mastocytosis without skin involvement are two emerging entities that sometimes might be clinically difficult to distinguish, and they involve a great challenge for the physician from both a ...
David González-de-Olano, Almudena Matito, Alberto Orfao, Luis Escribano   +3 more
doaj   +1 more source

Systemic mastocytosis with KIT V560G mutation presenting as recurrent episodes of vascular collapse: response to disodium cromoglycate and disease outcome

Allergy, Asthma & Clinical Immunology, 2017
Background Mastocytosis are rare diseases characterized by an accumulation of clonal mast cells (MCs) in one or multiple organs or tissues. Patients with systemic mastocytosis (SM), whose MCs frequently arbor the activating D816V KIT mutation, may have ...
Iolanda Conde-Fernandes, Rita Sampaio, Filipa Moreno, José Palla-Garcia, Maria dos Anjos Teixeira, Inês Freitas, Esmeralda Neves, Maria Jara-Acevedo, Luis Escribano, Margarida Lima   +9 more
doaj   +1 more source

Safety and Tolerability of a 3‐h Build‐Up Phase With Hymenoptera Venom Depot Extracts: Preliminary Results

Allergy, Volume 80, Issue 12, Page 3427-3429, December 2025.
Alessandro Buonomo, Roberta Massaro, David Longhino, Arianna Aruanno, Cristiano Caruso, Eleonora Nucera, Antonio Gasbarrini   +6 more
wiley   +1 more source

Indolent systemic mastocytosis [PDF]

, 2020
openaire   +3 more sources

Plenary Abstracts Session & Oral Presentations

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Poster Sessions

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Publication Only

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Avapritinib reduces symptoms and mast cell burden in systemic mastocytosis

Allergy, Asthma & Clinical Immunology
Background Mastocytosis is driven by a clonal expansion of mast cells, commonly triggered by the KIT D816V mutation which is present in over 90% of adult patients.
Paula Nöldeke, Oliver Schmalz, Hans Kvasnicka, Jens Panse, Silke C. Hofmann   +4 more
doaj   +1 more source